|
Hansa's imlifidase demonstrates remarkable efficacy in Guillain-Barré
Syndrome, enabling patients to walk independently 6 weeks faster than... Guillain–Barré syndrome, Hansa Biopharma, Medicine |
|
| More about this | ||
|
|
||
| ||
|
|
Hansa's imlifidase demonstrates remarkable efficacy in Guillain-Barré
Syndrome, enabling patients to walk independently 6 weeks faster than... Guillain–Barré syndrome, Hansa Biopharma, Medicine |
|
| More about this | ||
|
|
||
| ||